http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103156805-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b8f22aecbd06c70c8efe00ae4aa237e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26ed25f3feac102eae4ed421389c340f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2011-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_841e0bf057c5e368b07a3dcce8c6f455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60479d007e683fd9445dec2b9c7b53a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a342bd2c867a21b721c831bab08d38b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b736bce1b3a0f95be5da52663c7aefa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75ed6723d49a8c35b04c8d35194d0b26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a8ffdaffa088bcf96bba64a77fbeb8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb4e8b3bd9715849361c4dbff395d621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1994707ff753aefafce3d30dc3590d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b1a6e249c2c1b103da1e3f58f3b9a9c
publicationDate 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103156805-B
titleOfInvention Ciprofloxacin thermo-sensitive type in-situ gel composition and preparing method thereof
abstract The invention discloses ciprofloxacin thermo-sensitive type in-situ gel composition and belongs to the field of veterinary drug preparations. The thermo-sensitive type in-situ gel composition comprises, by weight volume (g/ml), 5%-10% of ciprofloxacin, 20%-26% of poloxamer 407, 0.5%-10% of poloxamer 188, 0.01%-0.04% of edetic acid, 0.009%-0.03% of bacteriostatic agent, and 0.1%-0.2% of antioxidant. Solvent of the composition is acetic acid - sodium acetate buffer solution. The invention further discloses a preparing method of the composition. The ciprofloxacin thermo-sensitive type in-situ gel composition is liquid at room temperature, jelling temperature is close to body temperature, and therefore dosing is convenient and jelling speed is high, jelling strength and adhering function are good, the dosing can be achieved with accurate positioning, and loss of drug is reduced. Furthermore, the ciprofloxacin thermo-sensitive type in-situ gel composition and the preparing method thereof have controlled-releasing and long-acting functions, dosage is low, the number of times of dosing is small, harm caused by implants normally used is avoided, and pain of patients is relieved.
priorityDate 2011-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID7091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448616730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451262756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID7091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450254702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447855610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23662384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421970820
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449013851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665763

Total number of triples: 51.